Evidence map›Paper›PMID 22114270›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

Calcium/calmodulin kinase II in the pedunculopontine tegmental nucleus modulates the initiation and maintenance of wakefulness.

Subimal Datta, Matthew W O'Malley, Elissa H Patterson

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The role of calcium and CaMKII in sleep.Frontiers in systems neuroscience · 2022
    Review
  5. Phosphorylation Hypothesis of Sleep.Frontiers in psychology · 2020
    Review
  6. Review
  7. Article
  8. Role of calcium channels in bipolar disorder.Current psychopharmacology · 2017
    Article
  9. Article
  10. Article
  11. Implications of gamma band activity in the pedunculopontine nucleus.Journal of neural transmission (Vienna, Austria : 1996) · 2016
    Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. About sleep's role in memory.Physiological reviews · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Subimal DattaLaboratory of Sleep and Cognitive Neuroscience, and Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118, USA. Subimal@bu.edu
Matthew W O'Malley
Elissa H Patterson
Institut des Sciences Cognitives Marc Jeannerod · FRBoston University · US

Funding

CELLULAR AND NEUROCHEMICAL MECHANISMS OF REM SLEEPR01MH059839 · NIMH · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI DATTA, SUBIMAL · 1999 to 2017
$5.7M
NIMH NIH HHS MH59839NIMH NIH HHS R01 MH059839
6 · The paper itself

Abstract

The pedunculopontine tegmentum nucleus (PPT) is critically involved in the regulation of wakefulness (W) and rapid eye movement (REM) sleep, but our understanding of the mechanisms of this regulation remains incomplete. The present study was designed to determine the role of PPT intracellular calcium/calmodulin kinase (CaMKII) signaling in the regulation of W and sleep. To achieve this aim, three different concentrations (0.5, 1.0, and 2.0 nmol) of the CaMKII activation inhibitor, KN-93, were microinjected bilaterally (100 nl/site) into the PPT of freely moving rats, and the effects on W, slow-wave sleep (SWS), REM sleep, and levels of phosphorylated CaMKII (pCaMKII) expression in the PPT were quantified. These effects, which were concentration-dependent and affected wake-sleep variables for 3 h, resulted in decreased W, due to reductions in the number and duration of W episodes; increased SWS and REM sleep, due to increases in episode duration; and decreased levels of pCaMKII expression in the PPT. Regression analyses revealed that PPT levels of pCaMKII were positively related with the total percentage of time spent in W (R(2) = 0.864; n = 28 rats; p < 0.001) and negatively related with the total percentage of time spent in sleep (R(2) = 0.863; p < 0.001). These data provide the first direct evidence that activation of intracellular CaMKII signaling in the PPT promotes W and suppresses sleep. These findings are relevant for designing a drug that could treat excessive sleepiness by promoting alertness.

Indexed as

AnimalsBenzenesulfonamidesBenzylaminesCalcium-Calmodulin-Dependent Protein Kinase Type 2MaleMicroinjectionsPedunculopontine Tegmental NucleusProtein Kinase InhibitorsRandom AllocationRatsRats, WistarSignal TransductionSleep StagesSulfonamidesWakefulnessBenzenesulfonamidesBenzylaminesCalcium-Calmodulin-Dependent Protein Kinase Type 2KN 93Protein Kinase InhibitorsSulfonamides

Identifiers

PMID22114270
PMCPMC3229030
OpenAlexW2048509568

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.